***Background.*** From June 2011 through December 2011, a cluster of KPC-producing *Klebsiella pneumoniae* colonization and infection occurred in the NIH Clinical Center. The Clinical Center has continued monitoring its immunocompromised patient population for carbapenem-resistant *Enterobacteriaceae* (CRE) using active surveillance and periodic environmental sampling.

***Methods.*** From January 2012 through March 2014, perirectal swabs were collected: on admission and weekly in the ICU and other high-risk wards, from patients recently hospitalized at other institutions or transferred out of the ICU, and monthly on all medical-surgical inpatients. Starting September 2013, swabs were collected from all patients admitted to non-behavioral health wards. Swabs were plated onto chromogenic CRE-selective media and incubated at 35°C for 18-24 h; or tested by *bla*~KPC~ PCR. Environmental surfaces were sampled using moistened gauze pads. Pigmented colonies were identified by MALDI-TOF MS and tested by *bla*~KPC~ PCR. CRE-colonized patients were isolated with dedicated nursing and 24-hour infection control adherence monitoring. Equipment and rooms were disinfected with bleach, hydrogen peroxide vapor, and/or UV light.

***Results.*** Of 13,762 orders for surveillance swabs, 11,754 swabs from 3,843 patients were collected, an 85% compliance rate, with the gap largely due to patient refusal. Most swabs were cultured (95.8%), with 4.2% tested directly by PCR. Among 15 patients who had newly identified CRE isolates, 11 were KPC + , of whom 1 had acquired the outbreak strain, and 4 isolates had other mechanisms of carbapenem resistance. Since July 2012, no instances of hospital transmission have been detected. Of 343 environmental samples, 12 (4.4%) grew CRE (9 sink drains, 1 faucet aerator, 1 handrail, and 1 medication room surface); all but two were epidemiologically linked to colonized patients.

***Conclusion.*** Stringent infection control measures, including direct observation of hand hygiene compliance and aggressive microbiological surveillance were associated with control of CRE transmission. The relative contributions of healthcare personnel and environmental contamination to the nosocomial spread of CRE remain to be delineated.
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